Login to Your Account



Stallergenes expands Latin America footprint via Alergo acquisition

By Sergio Held
Staff Writer

Friday, July 25, 2014
BOGOTA, Colombia – French health care company Stallergenes SA announced the acquisition of Argentina's Alergo Pharma Srl as part of a plan to boost its presence in Latin America, while focusing on the diagnosis and treatment of allergies through diverse allergen immunotherapy-based solutions.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription